approved glp 1 agonists GLP-1/GIP Receptor and Diabetic Retinopathy: What ODs Should Know GI Adverse Effects of Glucagon-Like

Sarkar DK, Jana D, Patil PS, Chaudhari KS, Chattopadhyay BK, Chikkala BR, Mandal S, Chowdhary P

J Lipid Res 1995;36:211-28.ArticlePubMed 79

When either of the selective COX-inhibitors were applied before NPW treatment, a moderate degeneration in mucous cells and moderate degeneration in glandular cells, inflammatory cell infiltration and submucosal edema were identified

Miriyala S, Thippakorn C, Chaiswing L, Xu Y, Noel T, Tovmasyan A, et al

Over one-third of the ACMG secondary findings genes have pharmacogenomic implications, emphasizing the need for clinicians to integrate genetic insights into prescribing practices